Hospital is first in WNY to offer non-invasive prostate cancer treatment

BUFFALO, New York — Buffalo-area hospitals can boast a series of innovations over the past 50 years, from developments that led to the first prostate cancer screening tests to new methods of treating blood clots and strokes. Today, the region’s physician researchers and clinicians continue to innovate and find new ways to treat diseases, develop new devices and equipment, and create new ways to provide care indoors and outdoors. outside hospitals. This story is part of a collection of examples of innovation at some of Western New York’s largest health systems.

In 1986, the PSA test for prostate cancer, developed by a scientist at Roswell Park Comprehensive Cancer Center, was approved for clinical use by the FDA and is now used worldwide.

Nearly 40 years later, the hospital continues to offer new tests and treatments for the disease, with the newest treatment offering fewer side effects and better results. High-intensity focused ultrasound treatment is delivered using advanced robotics, making it a new option for men who were previously only candidates for active monitoring.